
ALX Oncology Holdings Inc
NASDAQ:ALXO

Fundamental Analysis


Revenue & Expenses Breakdown
ALX Oncology Holdings Inc
Balance Sheet Decomposition
ALX Oncology Holdings Inc
Current Assets | 103m |
Cash & Short-Term Investments | 97.8m |
Receivables | 830k |
Other Current Assets | 4.3m |
Non-Current Assets | 18m |
Long-Term Investments | 9.2m |
PP&E | 9m |
Other Non-Current Assets | -110k |
Free Cash Flow Analysis
ALX Oncology Holdings Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
ALX Oncology Holdings Inc
Revenue
|
0
USD
|
Operating Expenses
|
-138m
USD
|
Operating Income
|
-138m
USD
|
Other Expenses
|
8m
USD
|
Net Income
|
-130m
USD
|
ALXO Profitability Score
Profitability Due Diligence
ALX Oncology Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
ALX Oncology Holdings Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
ALXO Solvency Score
Solvency Due Diligence
ALX Oncology Holdings Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
ALX Oncology Holdings Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALXO Price Targets Summary
ALX Oncology Holdings Inc
Dividends
Current shareholder yield for ALXO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?